Results overview: Found 6 records in 0.03 seconds.
Articles, 6 records found
Articles 6 records found  
1.
11 p, 342.7 KB Elective Recurrent Inguinal Hernia Repair : Value of an Abdominal Wall Surgery Unit / Rodrigues-Gonçalves, V. (Hospital Universitari Vall d'Hebron) ; Martínez-López, M. (Hospital Universitari Vall d'Hebron) ; Verdaguer-Tremolosa, M. (Hospital Universitari Vall d'Hebron) ; Martínez-López, P. (Hospital Universitari Vall d'Hebron) ; López Cano, Marc (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The aim of this study was to analyze the impact of an abdominal wall surgery unit on postoperative complications (within 90 days postoperatively), hernia recurrence and chronic postoperative inguinal pain after elective recurrent inguinal hernia repair. [...]
2023 - 10.1007/s00268-023-07080-8
World Journal of Surgery, Vol. 47 (june 2023) , p. 2425-2435  
2.
18 p, 826.7 KB Remote control of movement disorders using a photoactive adenosine A 2A receptor antagonist / Taura, Jaume (Universitat de Barcelona. Institut de Neurociències) ; Nolen, Ernest G. (Colgate University) ; Cabré Segura, Gisela (Universitat Autònoma de Barcelona. Departament de Química) ; Hernando Campos, Jordi (Universitat Autònoma de Barcelona. Departament de Química) ; Squarcialupi, Lucia (National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases (USA)) ; López Cano, Marc (Universitat de Barcelona. Institut de Neurociències) ; Jacobson, Kenneth A. (National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases (USA)) ; Fernández-Dueñas, Víctor (Universitat de Barcelona. Institut de Neurociències) ; Ciruela, Francisco (Universitat de Barcelona. Institut de Neurociències)
G protein-coupled adenosine receptors are promising therapeutic targets for a wide range of neuropathological conditions, including Parkinson's disease (PD). However, the ubiquity of adenosine receptors and the ultimate lack of selectivity of certain adenosine-based drugs have frequently diminished their therapeutic use. [...]
2018 - 10.1016/j.jconrel.2018.05.033
Journal of Controlled Release, Vol. 283 (August 2018) , p. 135-142  
3.
17 p, 1000.6 KB Optical control of adenosine A3 receptor function in psoriasis / López-Cano, Marc (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ; Filgaira, Ingrid (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ; Nolen, Ernest G. (Colgate University) ; Cabré Segura, Gisela (Universitat Autònoma de Barcelona. Departament de Química) ; Hernando Campos, Jordi (Universitat Autònoma de Barcelona. Departament de Química) ; Tosh, Dilip K. (National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases (USA)) ; Jacobson, Kenneth A. (National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases (USA)) ; Soler, Concepció (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ; Ciruela, Francisco (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental)
Psoriasis is a chronic and relapsing inflammatory skin disease lacking a cure that affects approximately 2% of the population. Defective keratinocyte proliferation and differentiation, and aberrant immune responses are major factors in its pathogenesis. [...]
2021 - 10.1016/j.phrs.2021.105731
Pharmacological Research, Vol. 170 (August 2021) , art. 105731  
4.
18 p, 5.7 MB Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects / López Cano, Marc (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ; Font Inglès, Joan (Institut de Química Avançada de Catalunya) ; Aso, Ester (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ; Sahlholm, Kristoffer (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ; Cabré Segura, Gisela (Universitat Autònoma de Barcelona. Departament de Química) ; Giraldo, Jesús (Universitat Autònoma de Barcelona. Institut de Neurociències) ; De Koninck, Yves (Université Laval. Department of Psychiatry and Neuroscience) ; Hernando Campos, Jordi (Universitat Autònoma de Barcelona. Departament de Química) ; Llebaria, Amadeu (Institut de Química Avançada de Catalunya) ; Fernández-Dueñas, Víctor (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ; Ciruela, Francisco (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental)
Background and Purpose: Opioid-based drugs are the gold standard medicines for pain relief. However, tolerance and several side effects (i. e. constipation and dependence) may occur upon chronic opioid administration. [...]
2021 - 10.1111/bph.15645
British Journal of Pharmacology, 2021  
5.
12 p, 2.3 MB Angiotensin II type 1/adenosine A receptor oligomers : a novel target for tardive dyskinesia / Oliveira, Paulo A. de (Universidade Federal de Santa Catarina, Trindade) ; Dalton, James A. R (Universitat Autònoma de Barcelona. Institut de Neurociències) ; López-Cano, Marc (Universitat de Barcelona. Institut de Neurociències) ; Ricarte, Adrià (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Morató, Xavier (Universitat de Barcelona. Institut de Neurociències) ; Matheus, Filipe C. (Universidade Federal de Santa Catarina, Trindade) ; Cunha, Andréia S. (Universidade Federal de Santa Catarina, Trindade) ; Müller, Christa E. (University of Bonn, Germany) ; Takahashi, Reinaldo N. (Universidade Federal de Santa Catarina, Trindade) ; Fernández-Dueñas, Víctor (Universitat de Barcelona. Institut de Neurociències) ; Giraldo, Jesús (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Prediger, Rui D. (Universidade Federal de Santa Catarina, Trindade) ; Ciruela, Francisco (Universitat de Barcelona. Institut de Neurociències)
Tardive dyskinesia (TD) is a serious motor side effect that may appear after long-term treatment with neuroleptics and mostly mediated by dopamine D receptors (DRs). Striatal DR functioning may be finely regulated by either adenosine A receptor (AR) or angiotensin receptor type 1 (ATR) through putative receptor heteromers. [...]
2017 - 10.1038/s41598-017-02037-z
Scientific reports, Vol. 7 (may 2017)  
6.
20 p, 2.1 MB Optical control of pain in vivo with a photoactive mGlu receptor negative allosteric modulator / Font Inglès, Joan (Universitat Autònoma de Barcelona. Institut de Neurociències) ; López-Cano, Marc (Institut d'Investigació Biomèdica de Bellvitge) ; Notartomaso, Serena (I.R.C.C.S. Neuromed, Pozzilli, Italy) ; Scarselli, Pamela (I.R.C.C.S. Neuromed, Pozzilli, Italy) ; Di Pietro, Paola (I.R.C.C.S. Neuromed, Pozzilli, Italy) ; Bresolí-Obach, Roger (Universitat Ramon Llull. Institut Químic de Sarrià-IQS) ; Battaglia, Giuseppe (I.R.C.C.S. Neuromed, Pozzilli, Italy) ; Malhaire, Fanny (Université de Montpellier) ; Rovira, Xavier (Université de Montpellier) ; Catena, Juanlo (Institut de Química Avançada de Catalunya) ; Giraldo, Jesús (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Pin, Jean-Philippe (Université de Montpellier) ; Fernández-Dueñas, Víctor (Institut d'Investigació Biomèdica de Bellvitge) ; Goudet, Cyril (Université de Montpellier) ; Nonell, Santi (Universitat Ramon Llull. Institut Químic de Sarrià-IQS) ; Nicoletti, Ferdinando (I.R.C.C.S. Neuromed, Pozzilli, Italy) ; Llebaria, Amadeu (Institut de Química Avançada de Catalunya) ; Ciruela, Francisco (Institut d'Investigació Biomèdica de Bellvitge)
Light-operated drugs constitute a major target in drug discovery, since they may provide spatiotemporal resolution for the treatment of complex diseases (i. e. chronic pain). JF-NP-26 is an inactive photocaged derivative of the metabotropic glutamate type 5 (mGlu) receptor negative allosteric modulator raseglurant. [...]
2017 - 10.7554/eLife.23545
eLife, Vol. 6 (april 2017)  

See also: similar author names
4 Lopez-Cano, M.
14 Lopez-Cano, Manuel
4 López-Cano, M.
14 López-Cano, Manuel
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.